Evidence map›Paper›PMID 21788591›Full record

ArticleCirculation2011

Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Jorge A Alvarez, E John Orav, James D Wilkinson, Lora E Fleming, David J Lee, Lynn A Sleeper, Paolo G Rusconi, Steven D Colan, Daphne T Hsu, Charles E Canter and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Jorge A AlvarezDepartment of Pediatrics (D820), Miller School of Medicine, University of Miami, P.O. Box 016820, Miami, FL 33101, USA.
E John Orav
James D Wilkinson
Lora E Fleming
David J Lee
Lynn A Sleeper
Paolo G Rusconi
Steven D Colan
Daphne T Hsu
Charles E Canter
Steven A Webber
Gerald F Cox
John L Jefferies
Jeffrey A Towbin
Steven E Lipshultz
Pediatric Cardiomyopathy Registry Investigators
New England Research Institutes · USTexas Children's Hospital · USBoston Children's Museum · USChildren's Hospital of Pittsburgh · USHarvard University · USSynZyme Technologies (United States) · USSt. Louis Children's Hospital · US

Funding

PEDIATRIC CARDIOMYOPATHY REGISTRYR01HL053392 · NHLBI · UNIVERSITY OF ROCHESTER · PI LIPSHULTZ, STEVEN EDWARD · 1995 to 2009
$8.3M
Baseline Predictors of Outcomes of Pediatric Dilated CardiomyopathyF31HL094100 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALVAREZ, JORGE ALEX · 2008 to 2010
$109k
NHLBI NIH HHS F31 HL094100NHLBI NIH HHS F31HL094100NHLBI NIH HHS R01 HL053392NHLBI NIH HHS R01HL53392
6 · The paper itself

Abstract

backgroundPediatric dilated cardiomyopathy (DCM) is the leading indication for heart transplantation after 1 year of age. Risk factors by etiology at clinical presentation have not been determined separately for death and transplantation in population-based studies. Competing risks analysis may inform patient prioritization for transplantation listing. METHODS AND

resultsThe Pediatric Cardiomyopathy Registry enrolled 1731 children diagnosed with DCM from 1990 to 2007. Etiologic, demographic, and echocardiographic data collected at diagnosis were analyzed with competing risks methods stratified by DCM etiology to identify predictors of death and transplantation. For idiopathic DCM (n=1192), diagnosis after 6 years of age, congestive heart failure, and lower left ventricular (LV) fractional shortening z score were independently associated with both death and transplantation equally. In contrast, increased LV end-diastolic dimension z score was associated only with transplantation, whereas lower height-for-age z score was associated only with death. For neuromuscular disease (n=139), lower LV fractional shortening was associated equally with both end points, but increased LV end-diastolic dimension was associated only with transplantation. The risks of death and transplantation were increased equally for older age at diagnosis, congestive heart failure, and increased LV end-diastolic dimension among those with myocarditis (n=272) and for congestive heart failure and decreased LV fractional shortening among those with familial DCM (n=79).

conclusionsRisk factors for death and transplantation in children varied by DCM etiology. For idiopathic DCM, increased LV end-diastolic dimension was associated with increased transplantation risk but not mortality. Conversely, short stature was significantly related to death but not transplantation. These findings may present an opportunity to improve the transplantation selection algorithm.

Indexed as

AdolescentCardiomyopathy, DilatedChildChild, PreschoolFemaleFollow-Up StudiesHeart TransplantationHumansInfantInfant, NewbornMaleMorbidityMyocarditisPatient SelectionPredictive Value of TestsRegistries

Identifiers

PMID21788591
PMCPMC3199969
OpenAlexW2128322417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.